Form 4: Dexcom Executive Michael Jon Brown Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
EVP and Chief Legal Officer of Dexcom, Michael Jon Brown, sold 13,000 shares of common stock to cover tax withholding obligations related to vesting RSUs.
Summary
- On March 12, 2025, Michael Jon Brown, EVP and Chief Legal Officer of Dexcom Inc., sold 13,000 shares of Dexcom's common stock at a price of $70.3801 per share.
- The sale was mandated by Dexcom's equity incentive plan to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Brown beneficially owns 105,602 shares of Dexcom common stock, which includes 86,490 unvested restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to an executive stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's performance or outlook.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself doesn't necessarily indicate a negative outlook on the company's future.
Comparison to Industry Standards
- Executive compensation practices, including the use of RSUs and 'sell to cover' tax strategies, are standard across publicly traded companies, including Dexcom's competitors like Medtronic, Abbott, and Senseonics.
- The vesting schedules and equity amounts are generally aligned with industry norms for executive-level compensation.
Stakeholder Impact
- The stock sale has a minimal impact on shareholders as it is a small percentage of the total outstanding shares and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/08/2022 | Grant date for 12,040 RSUs that vest through March 8, 2026. |
| 03/08/2023 | Grant date for 7,256 RSUs that vest through March 8, 2026. |
| 03/08/2024 | Grant date for 14,474 RSUs that vest through March 8, 2027. |
| 03/08/2025 | Grant date for 22,798 RSUs that vest through March 8, 2027. |
| 03/08/2025 | Grant date for 29,922 RSUs that vest through March 8, 2028. |
| 03/12/2025 | Date of the stock sale transaction. |
| 03/14/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.